BioSpace News Archive

Pediatric clinical staff and those in their care will soon benefit from a new relationship announced between Medline and Texas Children’s Hospital, a U.S. News & World Report Best Children’s Hospital Honor Roll organization.

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, today announced the appointment of Tammy Sarnelli as Global Head of Regulatory Affairs.

Digirad Corporation (NASDAQ:DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, today announced that its management team will be presenting at the LD 500 Virtual Conference, on Tuesday, September 1

Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”), today announced that it has engaged with certain shareholders to enter into voluntary lock-up agreements (the “Lock-up Agreements”) applying resale restrictions on up to 52,908,420 common shares (the “Restricted Shares”) extending the period of time before the shares become free trading.

Plakous Therapeutics, Inc. announced that it has signed a know-how license agreement with Mayo Clinic. The multi-year agreement will focus on understanding the results of a natural history study of the factors associated with necrotizing enterocolitis (NEC), a rare disease affecting premature babies. Plakous has received Orphan

Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, today affirmed the full availability of Triptodur ® (triptorelin), a twice yearly injectable gonadotropin releasing hormone agonist (GnRHa) for the treatment of pediatric

Premier Medical Laboratory Services (PMLS) is now offering saliva based COVID-19 diagnostic testing. An industry leading commercial diagnostic laboratory, PMLS is now able to provide diagnostic results based on samples from various specimen types including: saliva, nasopharyngeal swabs, nares swabs, sputum, nasal aspirate, and more.

ADA Leads 20 National Patient Advocate Groups Urging USPS Delivery Improvements

Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced the Company will host a webinar with University of Louisville School of Medicine to discuss smart glasses usage in healthcare.

The access information for the investor conference call remains as follows: Direct Toll / International – 1-(866) 831-8711 Domestic US/Canada - 1-(203) 518-9883 Program Title: Generex Biotechnology Conference Call Conference ID – 89636 Updated Agenda FDA response to Pre-IND briefing package for Ii-Key-SARS-CoV-2 vaccine Meeting with the Canadian National Research Council to discuss moving the Ii-Key-SARS-CoV-2 vaccine technology forward Completed the deal with Worldwide Digitech, LLC (